China's exportation growth of plant extracts is slowing down, the industry entered to adjustment phase


In recent years, the rapid development of plant extracts industry in food, medicine, chemical and other aspects is prosperous,it is China's traditional Chinese medicine products, an important export varieties. However, compared with 2015, 2016 plant extract industry export growth slowed down, the industry entered to adjustment phase.


Trade scale contraction


In 2016, China's plant extract trade scale contraction phenomenon: trade volume of 2.45 billion US dollars, decline 4.77%. Which exports 1.93 billion US dollars, down 10.93%; on the contrary, imports amounted to 520 million US dollars, an increase of up to 27.84%. Taking into account the exchange rate fluctuations in 2016 compared to 2015, the impact of the import and export trade trends to determine the dollar is the annual average exchange rate converted into RMB (the following statistics are in Renminbi units), after conversion The results showed that in 2016, the volume of China's extract trade was 16.17 billion yuan, up by 1.27%, but the growth rate dropped by 23.6 percentage points. Among them, the export volume was 12.72 billion yuan, down by 5.28%; the import value was 3.45 billion yuan, up by 35.95%.


The decline in the export of the extract was mainly due to the decline of the refined oil products. As a result of the adjustment of the market demand and the increasingly standardized customs supervision, the export of essential oil products was 3.58 billion yuan, down by 26.79%. The traditional extract, that is, non-essential oil products are in a steady state of growth, exports 9.13 billion yuan, up 7.03%. It can be seen that the root of the extract is relatively stable.


In 2016, China exported 150 products and products to 150 countries and regions. Asia, Europe and the Americas is the most important export market, exports accounted for nearly Jiucheng. Asia is the largest export market for extracts, 2016 China's exports to Asia amounted to 5.81 billion yuan, accounting for 45.7% of total exports by the ASEAN market, the sharp decline in refined oil products, China's exports to Asia fell 13.63% The While exports to Europe and North America due to non-essential oil products, the more stable, less volatile, exports were 2.72 billion yuan and 2.88 billion yuan.


From a single country level, the United States since 2011, will replace Japan as China's largest extract exporter. The extract is mainly used for the production of dietary supplements and food additives. Since the United States issued the Dietary Supplement Health and Education Act (DSHEA) in 1994, the dietary supplement industry developed at a rapid pace, with sharp increases in demand for raw materials and rigid characteristics of extract exports. In 2016, China's exports to the United States amounted to 2.77 billion yuan of exports, exports accounted for up to 21.76%, an increase of 5.88%.


Japan, followed by Korea. China's exports to Japan amounted to 1.44 billion yuan, up 1.16% year on year. In addition to the export of ordinary extracts, the export of raw materials of Kampo medicine is a major feature of the export of Japan. Japan's Kampo medicine industry on the great demand for raw materials, Kampo medicine extracts such as peony licorice soup, Mai Men Dong Tang, Wuling San, Jiawei Xiaoya San, exports reached 540 million yuan. China's exports to South Korea, although less than the United States and Japan, but because of South Korea's health care products and cosmetics industry boom and dazzling, exports amounted to 640 million yuan, an increase of 33.24%.


The remaining top 10 countries and regions, Spain, Germany, France and other Western European countries, exports were more stable, an increase of 20.95%, respectively, 13.77% and 9.15%. Hong Kong's exports to Hong Kong fell 2.04% year-on-year due to the decline in Hong Kong's port position. The rest of Southeast Asia and other countries, due to the decline in refined oil products, exports fell significantly.


Low concentration of export industry


In 2016, China's top 10 varieties of extract exports include: Stevia extract, eucalyptus oil, menthol, licorice extract, marigold extract, chili pigment, bilberry extract, rutin and its derivatives, orange Peptides, cinnamon oil and so on.


Stevia extract. In 2016, stevia extract to continue to export the top export extract, the annual export volume of up to 1.45 billion yuan. Stevia's main export markets are the United States and Malaysia. The United States is China's largest stevia export market, the export amount of 530 million yuan, exports accounted for 36.76% of total exports of stevia. Malaysia followed, the export volume of 390 million yuan, accounting for 26.74% of total exports of stevia. Stevia market is very concentrated, located in the United States and Malaysia after South Korea, Japan, Mexico and other countries, exports were only 120 million yuan, 0.7 billion and 0.6 billion, while the United States and Malaysia accounted for more than 60% The


Licorice extract. Due to the adverse economic environment, and the international market and because of the rapid growth in exports in previous years led to market saturation, nearly 3 years, licorice market growth is weak. 2016 exports 529 million yuan, an increase of 0.06%. Japan and the United States is the main export market for licorice extract, the total amount of the two exports accounted for 62.07% of total exports. In 2016, China's exports to Japan amounted to 170 million yuan, down 16.53 percent year on year, exports to the United States 160 million yuan, an increase of 37.08%. Licorice exports to feed more forms, 2016 licorice imports amounted to 310 million yuan, due to the weak export market, leading to licorice import trade also declined, down 1.55%.


Ginkgo biloba extract. Ginkgo biloba extract in the outbreak of growth in 2013, the export has maintained a slight growth trend. Although the domestic Ginkgo biloba extract industry in 2015 has undergone major adjustments, but in general a smaller impact on foreign trade, 2016 Ginkgo biloba exports increased, exports amounted to 220 million yuan, an increase of 26.67%, ginkgo leaf The standardization of the extract industry has had a certain impact.


China's Ginkgo biloba extract is mainly exported to North America, Europe and Asia, Japan and South Korea and other places, the United States is the largest export market, 2016 exports to the United States accounted for 37.51% of global exports, the US ginkgo leaf market is more stable, Exports to the United States amounted to 83.928 million yuan, an increase of 7.46%. South Korea market from 2015 to go beyond Germany, a ginkgo biloba extract the second largest market, exports to Korea amounted to 25,514,400 yuan, an increase of 41.64%, the market vitality. Germany is also the traditional export market for extracts, exports in Germany in 2016 amounted to 1988.5 million yuan, an increase of 22.27%.


Due to the tight domestic policy, the overall international trade market downturn, the competitive pressure increases, 2016 extract exports to reduce. China's total export of 2120 enterprises, compared with 2015 to reduce the 129, of which private enterprises in private enterprises to reduce the 124.


China's export of export industry is low, the main export for the private enterprises, state-owned enterprises and foreign-funded enterprises accounted for less proportion, but because of the strength of state-owned enterprises and foreign-funded enterprises, with economies of scale, the export value increased by 12.23% and 7.75 %, While private enterprises are slightly vulnerable, the amount of exports fell 11.79% year on year. Top 10 enterprises accounted for 23.77% of total exports of extract.


Multi-force industry can be stabilized


In order to actively respond to changes in the international situation, the government and industry and other parties have made efforts.


The government is actively playing its role in building a platform and policy orientation. December 2015 the State Council promulgated the "National Standardization System Construction and Development Plan (2016 - 2020)" proposed the development of modern standardized system with Chinese characteristics, and guide the industry "to cultivate the group standard" to "stimulate the market vitality." In January 2017, "Chinese medicine" along the way "development plan (2016 - 2020)" release, and strive to create a comprehensive pattern of Chinese medicine all-round opening up, and "along the way" along the country in the field of Chinese medicine exchanges and cooperation, Is bound to drive along the line of extract market development.


Industry - Specific Extracts Standards and Certification Assistance Industry Development. Under the auspices of the China Medicines Association, domestic enterprises are actively involved in the formulation of the International Business Standards for Plant Extracts, and have completed the development of two batches of standards. The third batch of standards will also be introduced at home and abroad. repercussions. At the same time, the Chamber of Commerce also actively interfaced the industry standard with the national standard. In 2016, the Chinese food and drug testing institute jointly screened international business standards such as ginseng, Polygonum cuspidatum and Ginkgo biloba extract, and applied for becoming a national food standard. In addition, the Chamber of Commerce and the United States National Health Foundation (NSF) for enterprises to build "plant extract quality supplier" certification (GEP certification). The certification to meet the requirements of the US FSMA Act, in the factory audit certification on the addition of integrity evaluation certification, to fill the gaps in the domestic GMP certification, to enter the FDA approved third-party certification to lay the foundation for the Chinese enterprises in the international market to create " New business card ".


National policies and regulations for the extract industry is mean to bring good opportunities for development, and industry standards and certification for enterprises to seize the opportunity to provide a good way. Although the current extract industry is in the adjustment phase, but with the industry standardization into the right track, with the international reputation gradually formed, the extract industry and the stability of the re-take off is worth looking forward to.